2019
The cytotoxic effect of ferrocene derivatives in combination with radiotherapy against cervical carcinoma cells
SKOUPILOVÁ, Hana; Vladimír RAK; Jindřich KARBAN; Jiří PINKAS; Roman HRSTKA et al.Základní údaje
Originální název
The cytotoxic effect of ferrocene derivatives in combination with radiotherapy against cervical carcinoma cells
Název česky
Cytotoxický účinek derivátů ferocenu v kombinaci s radioterapií v buněčných liniích karcinomu děložního čípku
Autoři
Vydání
Chemistry and biology of phytohormones and related substances, 2019
Další údaje
Typ výsledku
Prezentace na konferencích
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ne
Změněno: 22. 8. 2019 12:56, Mgr. Hana Kubušová, Ph.D.
Anotace
V originále
Cervical cancer is the the second most frequent female malignancy. Despite the availability of preventive screening program and vaccination against most prevalent „high-risk“ human papillomaviruses (HPV), approximately 400 women die due to cervical cancer each year in the Czech Republic. Optimal treatment choice depends on the stage of the disease. Early stages are treated by surgery. More advanced stages are usually treated with a combination of radiotherapy and chemotherapy. Most commonly used chemotherapeutic drug is still cisplatin, which has a good antitumor effect but also serious toxicity. This fact led us to the synthesis and testing of new potential anti-cancer organometallic compounds. A series of new structures based on ferrocene moiety was tested in vitro and showed even better efficiency than cisplatin.